Download PDF
Horm Metab Res 2020; 52(01): e1
DOI: 10.1055/a-1038-7478
Erratum
© Georg Thieme Verlag KG Stuttgart · New York

Correction: Anti-Tumor Activity and Safety of Multikinase Inhibitors in Advanced and/or Metastatic Thyroid Cancer: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

Marina Tsoli‡
1   1st Department of Propaupedic Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece
,
Krystallenia I. Alexandraki‡
1   1st Department of Propaupedic Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece
,
Maria-Eleni Spei‡
1   1st Department of Propaupedic Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece
,
Gregory A. Kaltsas
1   1st Department of Propaupedic Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece
,
Kosmas Daskalakis
1   1st Department of Propaupedic Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece
2   Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
› Author Affiliations
Further Information

Publication History

Publication Date:
06 November 2019 (online)

Also available at
    Permissions and Reprints

Correction to:

Anti-Tumor Activity and Safety of Multikinase Inhibitors in Advanced and/or Metastatic Thyroid Cancer: A Systematic Review and Network Meta-Analysis of Randomized Controlled TrialsHorm Metab Res 2020; 52(01): 25-31
DOI: 10.1055/a-1023-4214

Erratum

Anti-Tumor Activity and Safety of Multikinase Inhibitors in Advanced and/or Metastatic Thyroid Cancer: a Systematic Review and Network Meta-analysis of Randomized Controlled Trials

Marina Tsoli, Krystallenia I. Alexandraki, Maria-Eleni Spei, Gregory A. Kaltsas, Kosmas Daskalakis. Horm Metab Res.
DOI: 10.1055/a-1023-4214

The figures 1–4 in the HTML version of the efirst published article were supplementary ones and not the ones described in the figure legends. The correct figures were uploaded again.